Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in the Netherlands

International Journal of Cancer

Volumn 137, Issue 4, 2015, Pages 921-929

  Ripping, T M ^a   Verbeek, A L M ^a,b   Fracheboud, J ^c   De Koning, H J ^c   Van Ravesteyn, N T ^c   Broeders, M J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Dutch Ref Ctr Breast Cancer Screen   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER OVERDIAGNOSIS; CANCER SCREENING; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; YOUNG ADULT; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; PATHOLOGY; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NETHERLANDS;

EID: 84931567456     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29452     Document Type: Article

References (36)

1. Independent UK panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
2. Perry N, Broeders M, de Wolf C, et al., European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-Summary document. Ann Oncol 2008; 19: 614-22.
3. Jørgensen KJ, Gøtzsche PC., Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ (Online) 2009; 339: 206-9.
4. Martinez-Alonso M, Vilaprinyo E, Marcos-Gragera R, et al., Breast cancer incidence and overdiagnosis in Catalonia (Spain). Breast Cancer Res 2010; 12: R58.
5. Njor SH, Olsen AH, Blichert-Toft M, et al., Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ 2013; 346: f1064.
6. Waller M, Moss S, Watson J, et al., The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007; 16: 2257-61.
7. Zackrisson S, Andersson I, Janzon L, et al., Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006; 332: 689-92.
8. Puliti D, Paci E., The other side of technology: risk of overdiagnosis of breast cancer with mammography screening. Future Oncol 2009; 5: 481-91.
9. Biesheuvel C, Barratt A, Howard K, et al., Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007; 8: 1129-38.
10. Puliti D, Miccinesi G, Zappa M, et al., Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012; 14: R9.
11. Etzioni R, Gulati R, Mallinger L, et al., Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med 2013; 158: 831-8.
12. Zahl P-H, Jørgensen K, Gøtzsche P., Lead-time models should not be used to estimate overdiagnosis in cancer screening. J Gen Intern Med 2014; 29: 1283-6.
13. Puliti D, Duffy SW, Miccinesi G, et al., Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19: 42-56.
14. Duffy S, Parmar D., Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013; 15: R41.
15. Falk RS, Hofvind S, Skaane P, et al., Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer 2013; 133: 705-12.
16. Puliti D, Miccinesi G, Paci E., Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med 2011; 53: 131-3.
17. Ripping TM, Verbeek AL, van der Waal D, et al., Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts. Br J Cancer 2013; 109: 2467-71.
18. National Evaluation Team for Breast cancer screening. National evaluation of breast cancer screening in the Netherlands 1990-2011/2012. Rotterdam: Erasmus MC, 2014.
19. Integraal kankercentrum Nederland. Borstkanker incidentie. Available at: http://www.cijfersoverkanker.nl/selecties/incidentie-borstkanker/img54056bef6a0c4, 2012.
20. Centraal Bureau voor de Statistiek. Bevolking op eerste dag van de maand, geslacht vanaf 1950. Available at: http://statline.cbs.nl/StatWeb/selection/default.aspx?DM=SLNL&PA=82218NED&VW=T, 2012.
21. Clayton D, Schifflers E., Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 1987; 6: 449-67.
22. Clayton D, Schifflers E., Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 1987; 6: 469-81.
23. Holford TR., Understanding the effects of age, period, and cohort on incidence and mortality-rates. Annu Rev Public Health 1991; 12: 425-57.
24. Møller B, Weedon-Fekjær H, Hakulinen T, et al., The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005; 14: 117-28.
25. De Gelder R, Heijnsdijk EAM, Van Ravesteyn NT, et al., Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011; 33: 111-21.
26. De Gelder R, Fracheboud J, Heijnsdijk EAM, et al., Digital mammography screening: Weighing reduced mortality against increased overdiagnosis. Prev Med 2011; 53: 134-40.
27. Coldman A, Phillips N., Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ 2013; 10: E492-8.
28. Kalager M, Adami H-O, Bretthauer M, et al., Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012; 156: 491-9.
29. Duffy SW, Michalopoulos D, Sebuodegard S, et al., Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution. J Med Screen 2014; 21: 24-9.
30. Seppänen J, Heinävaara S, Anttila A, et al., Effects of different phases of an invitational screening program on breast cancer incidence. Int J Cancer 2006; 119: 920-4.
31. Njor SH, Nystrom L, Moss S, et al., Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies J Med Screen 2012; 19: 33-41.
32. Bluekens AMJ, Holland R, Karssemeijer N, et al., Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology 2012; 265: 707-14.
33. Esserman LJ, Thompson IM, Jr, Reid B., Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013; 8: 797-798.
34. Hersch J, Jansen J, Barratt A, et al., Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013; 346: f158.
35. Waller J, Douglas E, Whitaker KL,. Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open 2013; 3.
36. Brouckaert O, Schoneveld A, Truyers C,. Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers. Ann Oncol 2013; 24: 1847-52.